D. E. Shaw & Co., Inc.
- SEC CIK
- 0001009207
- Latest filing
- Aug 14, 2026
ARQT holding history
Arcutis Biotherapeutics, Inc. in every 13F filed by D. E. Shaw & Co., Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
ARQT overviewAll 13F holders of ARQTFull Q2 2026 holdings
- Shares (Q2 2026)
- 3,949,609
- Value
- $103.6M
- % of portfolio
- 0.1%
- Quarters held
- 13
- Since Q3 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 3,949,609 | $103.6M | 0.1% | +1,453,387+58.2% | Added | Holders |
| Q1 2026 | 2,496,222 | $58.8M | <0.1% | −186,865−7.0% | Reduced | Holders |
| Q4 2025 | 2,683,087 | $77.9M | 0.1% | +564,374+26.6% | Added | Holders |
| Q3 2025 | 2,118,713 | $39.9M | <0.1% | −44,288−2.0% | Reduced | Holders |
| Q2 2025 | 2,163,001 | $30.3M | <0.1% | +173,493+8.7% | Added | Holders |
| Q1 2025 | 1,989,508 | $31.1M | <0.1% | −524,069−20.8% | Reduced | Holders |
| Q4 2024 | 2,513,577 | $35.0M | <0.1% | +768,553+44.0% | Added | Holders |
| Q3 2024 | 1,745,024 | $16.2M | <0.1% | +737,640+73.2% | Added | Holders |
| Q2 2024 | 1,007,384 | $9.37M | <0.1% | +790,518+364.5% | Added | Holders |
| Q1 2024 | 216,866 | $2.15M | <0.1% | +216,866 | New | Holders |
| Q2 2023 | 0 | $0 | 0.0% | −10,629−100.0% | Sold out | Holders |
| Q1 2023 | 10,629 | $116.9K | <0.1% | −26,547−71.4% | Reduced | Holders |
| Q4 2022 | 37,176 | $550.2K | <0.1% | −37,200−50.0% | Reduced | Holders |
| Q3 2022 | 74,376 | $1.42M | <0.1% | +74,376 | New | Holders |